Author

Y Rahim

Observed names: Y. Rahim, Yassine Rahim

Institution: Kettering General Hospital

Observed institutions: Ontario Institute for Cancer Research, BC Cancer Agency, University of Toronto, Kettering General Hospital, Toronto East General Hospital, Princess Margaret Cancer Centre, Centre Hospitalier de l’Université de Montréal, Kingston Health Sciences Centre, Ottawa Hospital Research Institute, Cross Cancer Institute, Université de Montréal, McMaster University

OpenAlex ID: A5062875107

Abstract PD1-10: Randomized phase II study comparing two different schedules of palbociclib plus second line endocrine therapy in women with estrogen receptor positive, HER2 negative advanced/metastatic breast cancer: CCTG MA38 (NCT02630693)

2019 · WR Parulekar, AA Joy, et al. · Cancer Research · 8

Assessment of barriers to patient participation in clinical trials among oncology outpatients at a community teaching hospital in Toronto

2009 · L. Shamrakov, H. Sampson, et al. · Journal of Clinical Oncology · 1

P221 Feasibility and safety of single-port thoracoscopic pleurodesis with same-site indwelling pleural catheter insertion for management of malignant and unexplained exudative pleural effusion

2025 · Y Rahim, S Khan, et al.

P271 Impact of early versus delayed intrapleural fibrinolytics on pleural infection outcomes: an observational study

2025 · Y Rahim, M Zubair, et al.

Ki67 in young patients with breast cancer

2018 · Yassine Rahim · Journal of Clinical & Experimental Oncology

Assessment of barriers to patient participation in clinical trials among oncology outpatients at a community teaching hospital in Toronto.

2009 · L Shamrakov, H Sampson, et al. · Cancer Research

Works count: 6

Citation count: 9

H-index: 1

I10-index: